Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Pa... - 0 views
-
Lee Vander Loop on 21 Jun 10A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of USL255 as Adjunctive Therapy in Patients With Refractory Partial-Onset Seizures